Tris(1,1,1,3,3,3-hexafluoropropan-2-yl) phosphate, 98%, 5g

Biphenyl-3-carboxylic Acid>98.0%(GC)(T)1g

1-(pyrrolidin-3-yl)piperidine-4-carboxamide dihydrochloride, 95.0%, 250mg

5''-(4'-Amino-[1,1'-biphenyl]-4-yl)-[1,1':4',1'':3'',1''':4''',1''''-quinquephenyl]-4,4''''-diamine, 95%, 100mg

Tesofensine, 99.35%, 1g

1,4,5,8-Naphthalenetetracarboxylic dianhydride, 95.0%, 10g

5-Morpholin-4-yl-2-nitro-aniline, 95.0%, 1g

1,3-Diisopropoxy-1,1,3,3-tetramethyldisiloxane, 97%, 100mg

3'-Hydroxy-biphenyl-4-carbaldehyde, 1g

(R)-4-Hydroxydinaphtho[2,1-d:1',2'-f][1,3,2]dioxaphosphepine 4-oxide, 95.0%, 100g

2-(Hydroxymethyl)anthracene>98.0%(HPLC)1g

Sodium hydroxide solution 5%, extra pure, 25 l, plastic packaging.

Ethyl 4-hydroxypiperidine-1-carboxylate, 98.0%, 100g